微生物组工程:在炎症性肠病中释放治疗潜力
Chen Kong1, Long-Bin Huang1, Mei-Feng Yang2
1Department of Gastroenterology, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China.
工程微生物为炎症性肠病 (IBD) 提供了智能疗法. 合成生物学重新编程肠道细菌,酵母和菌体来检测疾病信号并提供向治疗,为新的IBD解决方案铺平了道路.
科学领域:
- 微生物学 微生物学
- 合成生物学 合成生物学
- 胃肠病学 胃肠病学
背景情况:
- 人的肠道微生物组包括对宿主恒温至关重要的非致病性微生物.
- 微生物组工程利用合成生物学来开发新的治疗方法.
- 炎症性肠病 (IBD) 是基于微生物组的干预措施的目标.
研究的目的:
- 审查工程微生物用于IBD治疗的最新进展.
- 突出合成生物学工具用于重新编程肠道微生物.
- 讨论工程微生物作为活体疗法的潜力.
主要方法:
- 用合成基因电路设计共生细菌,用于向药物输送.
- 利用菌体调节失生性肠道微生物群.
- 开发基于酵母的系统,用于代谢干预,例如酸盐生产.
主要成果:
- 工程微生物可以感知病理信号并提供有针对性的疗法.
- 合成基因电路使细菌能够进行精确的治疗.
- 菌体治疗和酵母系统为IBD管理提供了新的方法.
结论:
- 工程微生物代表IBD治疗的一个有希望的前沿.
- 生物封闭,遗传稳定性和临床翻译方面的挑战需要解决.
- 像外膜囊泡 (OMVs) 这样的新兴策略显示出免疫调节的潜力.
更多相关视频
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Microorganisms in Medicine and Therapeutics
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
